88.06% of Quest Diagnostics' stock owned by institutional investors, with Johnson Investment Counsel raising stake by 38.3%.

Quest Diagnostics has seen increased investment from institutional investors, with 88.06% of its stock now owned by them. Notable investors include Johnson Investment Counsel, which raised its stake by 38.3%. The company reported earnings of $2.35 per share for the second quarter, exceeding estimates by $0.04, and announced a quarterly dividend of $0.75. Its market cap stands at $17.18 billion, with analysts setting price targets between $144.00 and $165.00.

September 14, 2024
4 Articles

Further Reading